8-144095198-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001916.5(CYC1):āc.99T>Gā(p.Arg33Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.907 in 1,205,102 control chromosomes in the GnomAD database, including 497,423 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.87 ( 57859 hom., cov: 30)
Exomes š: 0.91 ( 439564 hom. )
Consequence
CYC1
NM_001916.5 synonymous
NM_001916.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.968
Genes affected
CYC1 (HGNC:2579): (cytochrome c1) This gene encodes a subunit of the cytochrome bc1 complex, which plays an important role in the mitochondrial respiratory chain by transferring electrons from the Rieske iron-sulfur protein to cytochrome c. Mutations in this gene may cause mitochondrial complex III deficiency, nuclear type 6. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 8-144095198-T-G is Benign according to our data. Variant chr8-144095198-T-G is described in ClinVar as [Benign]. Clinvar id is 379959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-144095198-T-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.968 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.974 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYC1 | NM_001916.5 | c.99T>G | p.Arg33Arg | synonymous_variant | 1/7 | ENST00000318911.5 | NP_001907.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYC1 | ENST00000318911.5 | c.99T>G | p.Arg33Arg | synonymous_variant | 1/7 | 1 | NM_001916.5 | ENSP00000317159.4 | ||
CYC1 | ENST00000533444.1 | n.160T>G | non_coding_transcript_exon_variant | 1/6 | 1 |
Frequencies
GnomAD3 genomes AF: 0.870 AC: 131514AN: 151248Hom.: 57838 Cov.: 30
GnomAD3 genomes
AF:
AC:
131514
AN:
151248
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.900 AC: 655AN: 728Hom.: 293 AF XY: 0.898 AC XY: 467AN XY: 520
GnomAD3 exomes
AF:
AC:
655
AN:
728
Hom.:
AF XY:
AC XY:
467
AN XY:
520
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.913 AC: 961689AN: 1053746Hom.: 439564 Cov.: 43 AF XY: 0.914 AC XY: 454256AN XY: 497264
GnomAD4 exome
AF:
AC:
961689
AN:
1053746
Hom.:
Cov.:
43
AF XY:
AC XY:
454256
AN XY:
497264
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.869 AC: 131586AN: 151356Hom.: 57859 Cov.: 30 AF XY: 0.872 AC XY: 64549AN XY: 73984
GnomAD4 genome
AF:
AC:
131586
AN:
151356
Hom.:
Cov.:
30
AF XY:
AC XY:
64549
AN XY:
73984
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3299
AN:
3428
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 15, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 02, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Mitochondrial complex III deficiency nuclear type 6 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at